Docetere 20mg Injection

1. Product Introduction

Docetere 20mg Injection is a chemotherapy medication that contains the active ingredient Docetaxel (20mg). It belongs to the class of anti-cancer agents known as taxanes, which work by interfering with the growth and spread of cancer cells in the body.

Docetaxel is a semi-synthetic derivative of a natural substance extracted from the needles of the European yew tree. It functions primarily by stabilizing microtubules, essential components of the cell structure that are necessary for cell division. By preventing the disassembly of microtubules, Docetaxel stops the cancer cells from dividing and leads to cell death.

Docetere Injection is administered intravenously under the supervision of trained medical professionals, typically in a hospital or oncology clinic. It plays a vital role in the treatment regimens of several common and aggressive cancers, especially when other treatments have not been successful.

2. Uses of This Medicine

Docetere 20mg Injection is used in the treatment of a wide range of cancers. It is either used as a standalone therapy or in combination with other chemotherapy drugs. Some of its major indications include:

• Breast Cancer

  • Often used in advanced or metastatic breast cancer and as part of neoadjuvant (before surgery) or adjuvant (after surgery) treatment.

• Non-Small Cell Lung Cancer (NSCLC)

  • Used in patients who are not candidates for surgery or have advanced disease.

• Prostate Cancer

  • Commonly combined with prednisone for metastatic hormone-refractory prostate cancer.

• Gastric (Stomach) Cancer

  • Especially used when cancer is advanced or has spread to other parts.

• Head and Neck Cancers

  • In combination therapies for advanced squamous cell carcinoma of the head and neck.

• Ovarian Cancer (off-label or clinical practice)

The exact treatment protocol, including frequency and dosage, is customized based on the patient’s condition, the type of cancer, and prior treatments received.

3. Benefits of This Medicine

• Broad-Spectrum Activity
  Docetaxel is highly effective against a range of aggressive tumors, including breast, prostate, lung, and gastric cancers, offering versatile applications.

• Improved Survival Rates
  Clinical studies have shown that Docetaxel-based regimens significantly improve progression-free survival (PFS) and overall survival (OS) in various cancers.

• Used in Combination for Better Results
  Often used with drugs like cisplatin, fluorouracil, or prednisone, Docetaxel enhances the therapeutic efficacy, providing superior cancer control.

• Proven Second-Line Treatment
  For many cancers that have not responded to initial therapy, Docetaxel serves as a powerful second-line treatment option.

• Reduces Tumor Size
  In some cases, Docetaxel is used before surgery to shrink tumors and improve the chances of successful surgical removal (neoadjuvant therapy).

4. Side Effects

While Docetere 20mg Injection is effective, it may cause side effects, which can range from mild to severe. Regular monitoring and supportive care can help manage these effects effectively.

Common Side Effects:

• Fatigue and weakness

• Nausea and vomiting

• Diarrhea

• Hair loss (temporary)

• Nail discoloration or brittleness

• Mouth sores (mucositis)

• Fluid retention leading to swelling

• Muscle or joint pain

Hematological Side Effects:

• Neutropenia (low white blood cell count), increasing infection risk

• Anemia (low red blood cells)

• Thrombocytopenia (low platelet count)

Serious Side Effects:

• Allergic reactions during infusion (rash, low blood pressure, difficulty breathing)

• Peripheral neuropathy (numbness or tingling in hands/feet)

• Liver dysfunction

• Severe infections (including sepsis)

Note: Patients are often pre-medicated with corticosteroids like dexamethasone to minimize allergic reactions and fluid retention.

5. Frequently Asked Questions (FAQ)

Q1. What is Docetere 20mg Injection used for?
Docetere is primarily used to treat various types of cancers, such as breast, lung, prostate, gastric, and head and neck cancers, either alone or in combination with other chemotherapy drugs.

Q2. How is Docetere Injection administered?
It is given as an intravenous infusion, usually over an hour, in a hospital or clinical setting under the supervision of an oncologist or trained nurse.

Q3. How often is Docetere given?
The standard regimen is once every 3 weeks, but this may vary depending on your condition, other medications, and how well you tolerate the treatment.

Q4. Are there any precautions to take before receiving Docetere?
Yes. Doctors usually prescribe corticosteroids (like dexamethasone) starting a day before the infusion to reduce the risk of allergic reactions and fluid retention. You should also have routine blood tests before each dose to check blood counts and liver function.

Q5. Can Docetere cause hair loss?
Yes, temporary hair loss is a common side effect. Hair typically starts growing back after treatment is completed.